233 Followers on Owler

Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders...

Read more

Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders...

Read more
Salix Pharmaceuticals President: Robert Spurr

President

Robert Spurr

CEO Approval Rating

82/100

Est. Annual Revenue
$1.0-5.0B
Agree?
Est. Employees
500-1.0K
Agree?
Funding
$60M
Acquisitions
3

News

Dec 01, 2022
FinanzNachrichten
Salix Pharmaceuticals: Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
Nov 04, 2022
FinanzNachrichten
Salix Pharmaceuticals: Salix Pharmaceuticals: Salix Will Present Rifaximin Data at AASLD's The Liver Meeting 2022
Oct 12, 2022
Cision Canada
Press Release: Salix Pharmaceuticals : SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION
Oct 03, 2022
MarketScreener
Salix Pharmaceuticals: SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY
Sep 09, 2022
StreetInsider
Press Release: Salix Pharmaceuticals : Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin
Jul 13, 2022
PR Newswire
Press Release: Salix Pharmaceuticals : Salix Announces 2022 Gastrointestinal Health Scholars Program Winners
Jun 20, 2022
MarketScreener
Salix Pharmaceuticals: Salix to Share New Data from XIFAXAN (Rifaximin) Clinical Research at EASL's International Liver Congress 2022
May 18, 2022
Markets Insider
Salix Pharmaceuticals: Salix Pharmaceuticals To Share New Data At Digestive Disease Week 2022
Apr 07, 2022
FirstWord Pharma
Salix Pharmaceuticals: Salix Pharmaceuticals Will Present Scientific Data at the Society of Hospital Converge 2022
Mar 24, 2022
MarketScreener
Salix Pharmaceuticals: New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy

Salix Pharmaceuticals Competitors

1
2
3
4
5
6
7
8
9
10

Salix Pharmaceuticals News

Salix Pharmaceuticals Press Releases

Salix Pharmaceuticals Headquarters

400 Somerset Corporate Boulevard

Bridgewater, New Jersey08807

1-800-321-4576

Driving Directions »

Salix Pharmaceuticals Summary

ABOUT

Overview

Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders. Salix Pharmaceuticals was founded in 1989. Salix Pharmaceuticals' headquarters is located in Bridgewater, New Jersey, USA 08807. Sal...

CEO

Salix Pharmaceuticals's President, Robert Spurr, currently has an approval rating of 82%. Salix Pharmaceuticals's primary competitors are Impax Laboratories, Llc, Taro & Lannett.

Website

salix.com

Investments

Recent investment data cannot be found related to Salix Pharmaceuticals

Frequently Asked Questions about Salix Pharmaceuticals

  1. When was Salix Pharmaceuticals founded?

    Salix Pharmaceuticals was founded in 1989
  2. Who is Salix Pharmaceuticals's CEO?

    Salix Pharmaceuticals's CEO is Robert Spurr
  3. How much revenue does Salix Pharmaceuticals generate?

    Salix Pharmaceuticals generates $1B in revenue
  4. How much funding does Salix Pharmaceuticals have?

    Salix Pharmaceuticals has historically raised $60M in funding
  1. Where is Salix Pharmaceuticals's headquarters?

    Salix Pharmaceuticals's headquarters is in Bridgewater New Jersey, USA
  2. How many employees does Salix Pharmaceuticals have?

    Salix Pharmaceuticals has 893 employees
  3. Who are Salix Pharmaceuticals's competitors?

    Salix Pharmaceuticals's top competitors are Impax Laboratories, Llc, Taro, Lannett

Trending Companies